175 related articles for article (PubMed ID: 228907)
1. Effect of cyproterone acetate (CPA) on gonadal and adrenal function in men.
de la Torre B; Norén S; Hedman M; Diczfalusy E
Contraception; 1979 Oct; 20(4):377-96. PubMed ID: 228907
[TBL] [Abstract][Full Text] [Related]
2. Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.
Moltz L; Römmler A; Post K; Schwartz U; Hammerstein J
Contraception; 1980 Apr; 21(4):393-413. PubMed ID: 6771095
[TBL] [Abstract][Full Text] [Related]
3. Use of low-dosage oral cyproterone acetate as a male contraceptive.
Wang C; Yeung KK
Contraception; 1980 Mar; 21(3):245-72. PubMed ID: 6771091
[TBL] [Abstract][Full Text] [Related]
4. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Falsetti L; Galbignani E
Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
[TBL] [Abstract][Full Text] [Related]
6. Studies on the pattern of circulating steroids in the normal menstrual cycle. Circadian variation in theperi-ovulatory period.
Aedo AR; Nuñez M; Landgren BM; Cekan SZ; Diczfalusy E
Acta Endocrinol (Copenh); 1977 Feb; 84(2):320-32. PubMed ID: 138325
[TBL] [Abstract][Full Text] [Related]
7. Studies on ovarian and adrenal studies at different phases of the menstrual cycle. IV. The effect of dexamethasone suppression and subsequent ACTH stimulation at different phases of the menstrual cycle and following the administration of 150 mg of depot-medroxy-progesterone acetate (DMPA).
Aedo AR; Landgren BM; Diczfalusy E
Contraception; 1981 Nov; 24(5):543-58. PubMed ID: 6274585
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
[TBL] [Abstract][Full Text] [Related]
9. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle: II. A comparative assessment of the circadian variation in steroid and lutropin levels during the follicular, periovulatory and luteal phases.
Aedo AR; Landgren BM; Diczfalusy E
Contraception; 1981 Apr; 23(4):407-24. PubMed ID: 7273761
[TBL] [Abstract][Full Text] [Related]
10. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. III. Steroid and lutropin levels before and after the administration of a single contraceptive dose of depot-medroxyprogesterone acetate (DMPA).
Aedo AR; Landgren BM; Diczfalusy E
Contraception; 1981 Aug; 24(2):117-35. PubMed ID: 6457729
[TBL] [Abstract][Full Text] [Related]
11. A study of the short-time variation and interrelationship of plasma hormone levels reflecting pituitary, adrenocortical and testicular function in fertile men.
de la Torre B; Sjöberg B; Hedman M; Bártfai G; Diczfalusy E
Int J Androl; 1981 Oct; 4(5):532-45. PubMed ID: 7319643
[TBL] [Abstract][Full Text] [Related]
12. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
13. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR
Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
Fulghesu AM; Lanzone A; Apa R; Fortini A; Caruso A; Mancuso S
Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
[TBL] [Abstract][Full Text] [Related]
15. Intratesticular steroid levels and their hormonal control.
Kim P; Hedman M; de la Torre B; Diczfalusy E
Steroids; 1985; 45(3-4):235-45. PubMed ID: 3010511
[TBL] [Abstract][Full Text] [Related]
16. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
Frölich M; Lachinsky N; Moolenaar AJ
Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
[TBL] [Abstract][Full Text] [Related]
17. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
[TBL] [Abstract][Full Text] [Related]
18. Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers.
Koch UJ; Lorenz F; Danehl K; Ericsson R; Hasan SH; Keyserlingk DV; Lübke K; Mehring M; Römmler A; Schwartz U; Hammerstein J
Contraception; 1976 Aug; 14(2):117-35. PubMed ID: 949890
[TBL] [Abstract][Full Text] [Related]
19. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
[TBL] [Abstract][Full Text] [Related]
20. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
Givens JR; Andersen RN; Ragland JB; Wiser WL; Umstot ES
J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
